Bilaketaren emaitzak - Stella, Péter

Pharmaceutical pricing, cost containment and new treatments for rare diseases in children nork Stella, Peter, Gold-von Simson, Gabrielle

Testu osoa Testu osoa Testu osoa

Prediction of Resuscitation for Pediatric Sepsis from Data Available at Triage nork Stella, Peter, Haines, Elizabeth, Aphinyanaphongs, Yindalon

Testu osoa Testu osoa

Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice nork Hidvégi, Tibor, Balogh, Zoltán, Vass, Viktor, Kovács, Gábor, Stella, Péter

Testu osoa Testu osoa Testu osoa

Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study nork Mathieu, Chantal, Weisnagel, S. John, Stella, Peter, Bruhwyler, Jacques, Alexandre, Kathy

Testu osoa Testu osoa Testu osoa

Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis nork Twigg, Stephen M., Escalada, Javier, Stella, Peter, Merino-Trigo, Ana, Lavalle-Gonzalez, Fernando J., Cariou, Bertrand, Meneghini, Luigi F.

Testu osoa Testu osoa Testu osoa

Validation of parsimonious prognostic models for patients infected with COVID-19 nork Harish, Keerthi, Zhang, Ben, Stella, Peter, Hauck, Kevin, Moussa, Marwa M, Adler, Nicole M, Horwitz, Leora I, Aphinyanaphongs, Yindalon

Testu osoa Testu osoa Testu osoa

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA nork Mauricio, Dídac, Meneghini, Luigi, Seufert, Jochen, Liao, Laura, Wang, Hongwei, Tong, Liyue, Cali, Anna, Stella, Peter, Carita, Paulo, Khunti, Kamlesh

Testu osoa Testu osoa Testu osoa

Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-Worl... nork Gupta, Shaloo, Wang, Hongwei, Skolnik, Neil, Tong, Liyue, Liebert, Ryan M., Lee, Lulu K., Stella, Peter, Cali, Anna, Preblick, Ronald

Testu osoa Testu osoa Testu osoa

The effect of concomitant DPPIVi use on glycaemic control and hypoglycaemia with insulin glargine 300 U/mL (Gla-300) versus insulin glargine 100 U/mL (Gla-100) in people with type... nork Yale, Jean-François, Pettus, Jeremy Hodson, Brito-Sanfiel, Miguel, Lavalle-Gonzalez, Fernando, Merino-Trigo, Ana, Stella, Peter, Chevalier, Soazig, Buzzetti, Raffaella

Testu osoa Testu osoa Testu osoa

Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score... nork Tabák, Ádám G., Anderson, John, Aschner, Pablo, Liu, Minzhi, Saremi, Aramesh, Stella, Peter, Tinahones, Francisco J., Wysham, Carol, Meier, Juris J.

Testu osoa Testu osoa Testu osoa

Glycaemic control and hypoglycaemia in people with type 2 diabetes switching from twice‐daily basal insulin to once‐daily insulin glargine 300 U/mL or insulin glargine 100 U/mL (ED... nork Roussel, Ronan, d'Emden, Michael C., Fisher, Miles, Ampudia‐Blasco, F. Javier, Stella, Peter, Bizet, Florence, Cali, Anna M. G., Wysham, Carol H.

Testu osoa Testu osoa Testu osoa

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting nork Meneghini, Luigi F., Mauricio, Didac, Orsi, Emanuela, Lalic, Nebojsa M., Cali, Anna M.G., Westerbacka, Jukka, Stella, Peter, Candelas, DEA, Christophe, Pilorget, Valerie, Perfetti, Riccardo, Khunti, Kamlesh

Testu osoa Testu osoa Testu osoa

Urinary NGAL Marks Cystic Disease in HIV-Associated Nephropathy nork Paragas, Neal, Nickolas, Thomas L., Wyatt, Christina, Forster, Catherine S., Sise, Meghan, Morgello, Susan, Jagla, Bernd, Buchen, Charles, Stella, Peter, Sanna-Cherchi, Simone, Carnevali, Maria Luisa, Mattei, Silvia, Bovino, Achiropita, Argentiero, Lucia, Magnano, Andrea, Devarajan, Prasad, Schmidt-Ott, Kai M., Allegri, Landino, Klotman, Paul, D'Agati, Vivette, Gharavi, Ali G., Barasch, Jonathan

Testu osoa Testu osoa Testu osoa

A validated, real-time prediction model for favorable outcomes in hospitalized COVID-19 patients nork Razavian, Narges, Major, Vincent J., Sudarshan, Mukund, Burk-Rafel, Jesse, Stella, Peter, Randhawa, Hardev, Bilaloglu, Seda, Chen, Ji, Nguy, Vuthy, Wang, Walter, Zhang, Hao, Reinstein, Ilan, Kudlowitz, David, Zenger, Cameron, Cao, Meng, Zhang, Ruina, Dogra, Siddhant, Harish, Keerthi B., Bosworth, Brian, Francois, Fritz, Horwitz, Leora I., Ranganath, Rajesh, Austrian, Jonathan, Aphinyanaphongs, Yindalon

Testu osoa Testu osoa Testu osoa